About
Protembis GmbH is a medical technology company based in Aachen, Germany, founded in 2013. The company specializes in developing catheter-based cerebral protection devices aimed at reducing the risk of brain injury and stroke during cardiology procedures, particularly transcatheter aortic valve replacement (TAVR). Their flagship product, the ProtEmbo® Cerebral Protection System, is a next-generation embolic protection device that uses a catheter-based filter system. This system is designed to block embolic particles while allowing blood cells to pass, thereby protecting patients from silent brain infarcts and strokes during heart valve replacement procedures. Protembis has conducted multiple clinical trials in Europe, showing that 94% of patients treated with ProtEmbo® were free of clinically meaningful brain lesions. The company is also expanding its presence in the US with Protembis Inc. to support ongoing clinical trials and aims for broader regulatory approvals.
Technologies
Keywords
Company Information
-
Employees 25
-
Founded 2013
-
Annual Revenue $4500000
-
Total Funding $64146700
Location
17 Pauwelsstrasse, Aachen, North Rhine-Westphalia, Germany, 52074
